Mirum Pharmaceuticals (MIRM) PT Raised to $129 at Baird

May 7, 2026 4:28 AM

Baird analyst Brian Skorney raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $129.00 (from $112.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found